| 000 | 01192 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513102250.0 | ||
| 264 | 0 | _c19970103 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a1660-8151 | ||
| 024 | 7 |
_a10.1159/000189174 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aal Shohaib, S | |
| 245 | 0 | 0 |
_aIntravenous immunoglobulins modify the response to erythropoietin in a CAPD patient. _h[electronic resource] |
| 260 |
_bNephron _c1996 |
||
| 300 |
_a720 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAnemia _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aErythropoietin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Passive |
| 650 | 0 | 4 |
_aImmunoglobulins _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xetiology |
| 650 | 0 | 4 |
_aLupus Nephritis _xcomplications |
| 650 | 0 | 4 |
_aPeritoneal Dialysis, Continuous Ambulatory _xadverse effects |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 700 | 1 | _aAbunijem, Z | |
| 773 | 0 |
_tNephron _gvol. 73 _gno. 4 _gp. 720 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000189174 _zAvailable from publisher's website |
| 999 |
_c8850430 _d8850430 |
||